Correlation Between Complexity of Coronary Lesions and Delta High-sensitivity Troponin (hs-cTn) I Levels in Patients of Non-ST Elevation Myocardial Infarction : Complexity of Coronary Lesions and Delta High-sensitivity Troponin I in Non-ST Elevation Myocardial Infarction

Muhammad Hammad Azam; Muhammad Abdul Wahab; Naveed Danish; Muhammad Taha; Shitba  Naeem; Shaheer Khan  Muhammad

doi:10.54393/pjhs.v5i09.2039

Authors

Muhammad Hammad Azam Clinical Fellow Cardiology, National Institute of Cardiovascular Diseases, Karachi, Pakistan
Muhammad Abdul Wahab Fellow Interventional Cardiology, Medical Teaching Institution-Hayatabad Medical Complex, Peshawar, Pakistan
Naveed Danish Fellow Interventional Cardiology, Medical Teaching Institution-Hayatabad Medical Complex, Peshawar, Pakistan
Muhammad Taha National Institute of Cardiovascular Diseases, Karachi, Pakistan
Shitba Naeem National Institute of Cardiovascular Diseases, Karachi, Pakistan
Shaheer Khan Muhammad National Institute of Cardiovascular Diseases, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i09.2039

Keywords:

Non-ST Elevation Myocardial Infarction, Syntax Score, Coronary Lesion, Myocardial Injury

Abstract

Non-ST Elevation Myocardial Infarction is a critical condition where early identification of myocardial injury is essential for risk stratification and treatment. High-sensitivity cardiac troponin I (hs-cTnI) is a well-established biomarker for detecting myocardial damage. Objectives: To assess the association between Syntax scores and initial significant delta hs-cTnI in patients who had been hospitalized with Non-ST Elevation Myocardial Infarction. Methods: Observational cohort study from January 2022 to December 2022 involving a total of one hundred and fifty patients admitted at Hayatabad Medical Complex Peshawar. hs-cTnI on admission and at 1, 2 hours and between (6h-12 h) post-admission daily was measured. Coronary lesion complexity was assessed with Syntax scores according to the results of coronary angiography. Statistical Analysis of data was performed using Pearson correlation to analyze the association between syntax scores delta hs-cTnI levels. Results: SYNTAX scores were correlated with Δhs-cTnI levels at all-time points, and the strongest correlation was found 6-12 hours post-admission (r=0.78). The syntax score had a mean value of 24.11 ± 14.74, and hs-cTnI levels increased over time to reflect the extent of myocardial injury. Conclusions: It was concluded that in Non-ST Elevation Myocardial Infarction patients, Syntax scores demonstrating more complex coronary lesions are related to higher delta hs-cTnI levels. This value highlights the use of hs-cTnI as a biomarker to evaluate the severity of myocardial injury and direct clinical decision-making in Non-ST Elevation Myocardial Infarction. Delta hs-cTnI measurements in diagnostic and risk stratification algorithms may lead to enhanced early identification of disease with improved outcomes.

References

Eggers KM and Lindahl B. High-Sensitivity Cardiac Troponin T, Age, and Outcome in Non-St-Elevation Myocardial Infarction. Clinical Chemistry. 2021 Dec; 67(12): 1732-4. doi: 10.1093/clinchem/hvab214. DOI: https://doi.org/10.1093/clinchem/hvab214

Yang S, Zhang Q, Yang B, Li Z, Sun W, Cui L. Analytical and Clinical Performance Evaluation of a New High-Sensitivity Cardiac Troponin I Assay. Clinical Chemistry and Laboratory Medicine. 2022 Jul; 60(8): 1299-307. doi: 10.1515/cclm-2021-1136. DOI: https://doi.org/10.1515/cclm-2021-1136

Limkakeng Jr AT, Hertz J, Lerebours R, Kuchibhatla M, McCord J, Singer AJ et al. Ideal High Sensitivity Troponin Baseline Cutoff for Patients with Renal Dysfunction. The American Journal of Emergency Medicine. 2021 Aug; 46: 170-5. doi: 10.1016/j.ajem.2020.06.072. DOI: https://doi.org/10.1016/j.ajem.2020.06.072

Farmakis D, Mueller C, Apple FS. High-Sensitivity Cardiac Troponin Assays for Cardiovascular Risk Stratification in the General Population. European Heart Journal. 2020 Nov; 41(41): 4050-6. doi: 10.1093/eurheartj/ehaa083. DOI: https://doi.org/10.1093/eurheartj/ehaa083

Bahadur K, Ijaz A, Salahuddin M, Alam A. Determination of High Sensitive Cardiac Troponin I 99th Percentile Upper Reference Limits in a Healthy Pakistani Population. Pakistan Journal of Medical Sciences. 2020 Sep; 36(6): 1303. doi: 10.12669/pjms.36.6.2328. DOI: https://doi.org/10.12669/pjms.36.6.2328

Ljung L, Reichard C, Hagerman P, Eggers KM, Frick M, Lindahl B et al. Sensitivity of Undetectable Level Of High-Sensitivity Troponin T at Presentation in a Large Non-ST-Segment Elevation Myocardial Infarction Cohort of Early Presenters. International Journal of Cardiology. 2019 Jun; 284: 6-11. doi: 10.1016/j.ijcard.2018.10.088. DOI: https://doi.org/10.1016/j.ijcard.2018.10.088

Tveit SH, Myhre PL, Hoff NJ, Le TM, Seljeflot I, Røysland R et al. Superiority of High Sensitivity Cardiac Troponin T Vs. I for Long-Term Prognostic Value in Patients with Chest Pain; Data from the Akershus Cardiac Examination (ACE) 3 Study. Clinical Biochemistry. 2020 Apr; 78: 10-7. doi: 10.1016/j.clinbiochem.2019.12.016. DOI: https://doi.org/10.1016/j.clinbiochem.2019.12.016

Šulskutė K, Pilkienė A, Meškėnė E, Kersnauskaitė D, Šerpytis R, Petrulionienė Ž et al. High-Sensitivity Cardiac Troponin Impact on the Differential Diagnosis of Non-ST Segment Elevation Coronary Syndromes—Is It Helping? Medicina. 2022 Aug; 58(8): 1084. doi: 10.3390/medicina58081084. DOI: https://doi.org/10.3390/medicina58081084

Han JH, Hwang SO, Cha KC, Roh YI, Kim SJ, Kim HS et al. High-sensitivity Troponin I Assay for Differential Diagnosis of New-Onset Myocardial Infarction in Patients with Acute Decompensated Heart Failure. Yonsei Medical Journal. 2021 Feb; 62(2): 129. doi: 10.3349/ymj.2021.62.2.129. DOI: https://doi.org/10.3349/ymj.2021.62.2.129

Westwood ME, Armstrong N, Worthy G, Fayter D, Ramaekers BL, Grimm S et al. Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-Out of Myocardial Infarction in Patients Presenting With Chest Pain: A Systematic Review. Clinical Chemistry. 2021 Jan; 67(1): 237-44. doi: 10.1093/clinchem/hvaa280. DOI: https://doi.org/10.1093/clinchem/hvaa280

Pickering JW, Young JM, George PM, Pemberton CJ, Watson A, Aldous SJ et al. Early Kinetic Profiles of Troponin I and T Measured by High-Sensitivity Assays in Patients with Myocardial Infarction. International Journal of Clinical Chemistry. 2020 Jun; 505: 15-25. doi: 10.1016/j.cca.2020.02.009. DOI: https://doi.org/10.1016/j.cca.2020.02.009

Dongxu C, Yannan Z, Yilin Y, Chenling Y, Guorong G, Kouqiong W et al. Evaluation of The 0 h/1 h High-Sensitivity Cardiac Troponin T Algorithm in Diagnosis of Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) in Han population. Clinical Chemistry and Laboratory Medicine. 2021 Mar; 59(4): 757-64. doi: 10.1515/cclm-2020-0367. DOI: https://doi.org/10.1515/cclm-2020-0367

Al-Assaf OY, Musa A, Alkazim HH, Benny SC, Binbrek AS. New Cutoff for High Sensitivity Troponin to Better Risk Stratify Patients with Non-ST Elevated Myocardial Infarction. World Journal of Cardiovascular Diseases. 2021 Jan; 11(01): 25. doi: 10.4236/wjcd.2021.111004. DOI: https://doi.org/10.4236/wjcd.2021.111004

Hussein AA, Al-bayati AA, Issa AH. Evaluation of the Diagnostic Value and Differentiation Efficacy of High Sensitivity Cardiac Troponin T2 (hscTnT2) for STEMI and NSTEMI Iraqi Patients with Acute Coronary Syndrome. Biomedicine. 2023 Jul; 43(3): 850-4. doi: 10.51248/.v43i3.2507. DOI: https://doi.org/10.51248/.v43i3.2507

Widera C, Giannitsis E, Mueller-Hennessen M, Reimann I, Guba-Quint A, Marquardt I et al. Diagnostic and Prognostic Value of Sex-And Age-Specific Cutpoints for High-Sensitivity Troponin T in Non-ST-Elevation Acute Coronary Syndrome. International Journal of Cardiology. 2019 Jan; 275: 13-9. doi: 10.1016/j.ijcard.2018.10.027. DOI: https://doi.org/10.1016/j.ijcard.2018.10.027

Bonett DG and Wright TA. Sample Size Requirements for Estimating Pearson, Kendall and Spearman Correlations. Psychometrika. 2000 Mar; 65: 23-8. doi: 10.1007/BF02294183. DOI: https://doi.org/10.1007/BF02294183

Liu L and Lewandrowski K. Establishing Optimal Cutoff Values for High-Sensitivity Cardiac Troponin Algorithms in Risk Stratification of Acute Myocardial Infarction. Critical Reviews in Clinical Laboratory Sciences. 2024 Jan; 61(1): 1-22. doi: 10.1080/10408363.2023.2235426. DOI: https://doi.org/10.1080/10408363.2023.2235426

Ohtake H, Ishii J, Nishimura H, Kawai H, Muramatsu T, Harada M et al. Prospective Validation of 0-hour/1-Hour Algorithm Using High-Sensitivity Cardiac Troponin I in Japanese Patients Presenting to Emergency Department. European Heart Journal. 2020 Nov; 41(Supplement_2): ehaa946-1707. doi: 10.1093/ehjci/ehaa946.1707. DOI: https://doi.org/10.1093/ehjci/ehaa946.1707

Restan I, Steiro OT, Tjora HL, Langoergen J, Omland T, Collinson P et al. Adding Stress Biomarkers to High-Sensitivity Troponin Measurements Increases Precision and Efficacy of Rapid Rule Out Protocols for NSTEMI. European Heart Journal. 2020 Nov; 41(Supplement_2): ehaa946-1698. doi: 10.1093/ehjci/ehaa946.1698. DOI: https://doi.org/10.1093/ehjci/ehaa946.1698

Tjora HL, Steiro OT, Langørgen J, Bjørneklett RO, Skadberg Ø, Bonarjee VV et al. Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome. Clinical Chemistry. 2022 Feb; 68(2): 291-302. doi: 10.1093/clinchem/hvab225. DOI: https://doi.org/10.1093/clinchem/hvab225